Annis Gardner Whiting Capital Advisors, LLC

Position in NVO — Novo Nordisk A S

CIK 1998414 TAMPA, FL

Back to NVO Full portfolio

Position in NVO

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$2,821,652

+$684,236 QoQ

Shares Held

58,858

+1.2% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.61%

of 13F equity value

Holder Rank

#309

of 1,348 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Annis Gardner Whiting Capital Advisors, LLC holds $18,574,820 across 10 Drug Manufacturers - General names. NVO ranks #3 (15.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	19,005	$4,826,699
2	AMGN	Amgen Inc	7,897	$2,859,661
3	NVO	Novo Nordisk A S This page	58,858	$2,821,652
4	LLY	ELI LILLY & Co	1,713	$2,054,623
5	ABBV	AbbVie Inc.	6,840	$1,721,217
6	PFE	Pfizer Inc	61,427	$1,479,162
7	BIIB	Biogen Inc.	5,233	$1,130,641
8	MRK	Merck & Co., Inc.	8,338	$1,071,433

All Filings in NVO

Export CSV

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,821,652	58,858	+1.2%	Shares	Sole	2026-08-10
2026-03-31	$2,137,416	58,161	+677.6%	Shares	Sole	2026-05-06
2025-12-31	$380,582	7,480	0.0%	Shares	Sole	2026-02-09
2025-09-30	$415,065	7,480	+358.9%	Shares	Sole	2025-11-03
2025-06-30	$112,502	1,630	+44.2%	Shares	Sole	2025-08-11
2025-03-31	$78,467	1,130	-23.7%	Shares	Sole	2025-05-09
2024-12-31	$127,395	1,481	0.0%	Shares	Sole	2025-02-12
2024-09-30	$176,342	1,481	-35.8%	Shares	Sole	2024-11-14
2024-06-30	$329,301	2,307	-1.7%	Shares	Sole	2024-08-12
2024-03-31	$301,483	2,348	+56.4%	Shares	Sole	2024-05-13
2023-12-31	$155,278	1,501	0.0%	Shares	Sole	2024-02-09
2023-09-30	$136,500	1,501	—	Shares	Sole	2023-11-08
No filing history on record for this holder in this stock.